Impact of risk minimisation in patients treated with rosiglitazone-containing productsFirst published 26/01/2011 Last updated 02/07/2024 EU PAS number: EUPAS1777StudyFinalised
Aarhus University & Aarhus University Hospital DEPARTMENT OF CLINICAL EPIDEMIOLOGYDenmark First published: 20/07/2021Last updated 02/04/2024 InstitutionEducational InstitutionENCePP partner
Aarhus University & Aarhus University Hospital DEPARTMENT OF CLINICAL EPIDEMIOLOGYDenmark First published: 20/07/2021Last updated 02/04/2024 InstitutionEducational InstitutionENCePP partner